Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001952728 | SCV002208651 | likely benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002484652 | SCV002782764 | uncertain significance | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003994360 | SCV004813203 | uncertain significance | not specified | 2024-02-21 | criteria provided, single submitter | clinical testing | Variant summary: CACNA1H c.637G>A (p.Val213Met) results in a conservative amino acid change located in the Ion transport domain (IPR005821) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 247820 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.637G>A in individuals affected with Idiopathic Generalized Epilepsy and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1433795). Based on the evidence outlined above, the variant was classified as uncertain significance. |